Titel	Veröffentlichungsdatum	Sprache	Zitate
Drug resistance and combating drug resistance in cancer	2019/01/01		230
Venetoclax resistance: mechanistic insights and future strategies	2022/01/01		31
Drug and apoptosis resistance in cancer stem cells (CSCs): A puzzle with many pieces	2022/01/01		16
Emerging targets in cancer drug resistance	2019/01/01		15
Improving HER2 testing reproducibility in HER2-low breast cancer	2022/01/01		13
Sphingolipid metabolism and drug resistance in ovarian cancer	2018/01/01		13
Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions	2020/01/01		13
Mechanisms of chemotherapy resistance in ovarian cancer	2022/01/01		12
An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer	2022/01/01		12
An overview of resistance to chemotherapy in osteosarcoma and future perspectives	2022/01/01		11
Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer	2018/01/01		11
Ovarian cancer recurrence: is the definition of platinum resistance modified by PARPi and other intervening treatments? The evolving landscape in the management of platinum-resistant ovarian cancer	2022/01/01		11
Role of prostate cancer stem-like cells in the development of antiandrogen resistance	2022/01/01		10
Loss of HER2 in breast cancer: biological mechanisms and technical pitfalls	2022/01/01		9
Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects	2023/01/01		8
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system	2023/01/01		7
Mitochondria in colorectal cancer stem cells - a target in drug resistance	2023/01/01		7
Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance	2022/01/01		7
Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma	2023/01/01		7
Mitochondrial determinants of chemoresistance	2019/01/01		7
Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance	2022/01/01		6
Mechanisms of acquired resistance to fibroblast growth factor receptor targeted therapy	2019/01/01		6
DNA damage and metabolic mechanisms of cancer drug resistance	2022/01/01		6
Ovarian cancer recurrence: “is the definition of platinum resistance modified by PARP inhibitors and other intervening treatments?”	2022/01/01		6
Ovarian cancer recurrence: is the definition of platinum sensitivity modified by PARPi, bevacizumab or other intervening treatments? : a clinical perspective	2022/01/01		6
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response	2022/01/01		6
Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer	2022/01/01		6
The complex relationship between multiple drug resistance and the tumor pH gradient: a review	2022/01/01		6
Influence of lysosomal sequestration on multidrug resistance in cancer cells	2019/01/01		6
Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer	2022/01/01		6